Generation of TWO G51D SNCA missense mutation iPSC lines (CRICKi011-A, CRICKi012-A) from two individuals at risk of Parkinson's disease


Mutations or multiplications of the SNCA (Synuclein Alpha) gene cause rare autosomal dominant Parkinson's disease (PD). The SNCA G51D missense mutation is associated with a synucleinopathy that shares PD and multiple system atrophy (MSA) characteristics. We generated induced pluripotent stem cell (iPSC) lines from two individuals with SNCA G51D missense mutations at risk of PD. Dermal fibroblasts were reprogrammed to pluripotency using a non-integrating mRNA-based protocol. The resulting human iPSCs displayed normal morphology, expressed markers associated with pluripotency, and differentiated into the three germ layers. The iPSC lines could facilitate disease-modelling and therapy development studies for synucleinopathies. Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.

Authors Devito LG, Zanjani ZS, Evans JR, Scardamaglia A, Houlden H, Gandhi S, Healy L
Journal Stem cell research
Publication Date 2023 Sep;71:103134
PubMed 37336145
DOI 10.1016/j.scr.2023.103134

Research Projects

Cell Lines